1. F12‐46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedema. Issue 12 (26th August 2015) Authors: Speletas, M.; Szilágyi, Á.; Csuka, D.; Koutsostathis, N.; Psarros, F.; Moldovan, D.; Magerl, M.; Kompoti, M.; Varga, L.; Maurer, M.; Farkas, H.; Germenis, A. E. Journal: Allergy Issue: Volume 70:Issue 12(2015:Dec.) Page Start: 1661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study. Issue 1 (5th November 2012) Authors: Reshef, A.; Moldovan, D.; Obtulowicz, K.; Leibovich, I.; Mihaly, E.; Visscher, S.; Relan, A. Journal: Allergy Issue: Volume 68:Issue 1(2013:Jan.) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update. Issue 8 (12th March 2018) Authors: Maurer, M.; Magerl, M.; Ansotegui, I.; Aygören‐Pürsün, E.; Betschel, S.; Bork, K.; Bowen, T.; Balle Boysen, H.; Farkas, H.; Grumach, A. S.; Hide, M.; Katelaris, C.; Lockey, R.; Longhurst, H.; Lumry, W. R.; Martinez‐Saguer, I.; Moldovan, D.; Nast, A.; Pawankar, R.; Potter, P. Journal: Allergy Issue: Volume 73:Issue 8(2018) Page Start: 1575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗